Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Sci Transl Med ; 16(764): eadg1777, 2024 Sep 11.
Article in English | MEDLINE | ID: mdl-39259812

ABSTRACT

Aging is a complex multifactorial process associated with epigenome dysregulation, increased cellular senescence, and decreased rejuvenation capacity. Short-term cyclic expression of octamer-binding transcription factor 4 (Oct4), sex-determining region Y-box 2 (Sox2), Kruppel-like factor 4 (Klf4), and cellular myelocytomatosis oncogene (cMyc) (OSKM) in wild-type mice improves health but fails to distinguish cell states, posing risks to healthy cells. Here, we delivered a single dose of adeno-associated viruses (AAVs) harboring OSK under the control of the cyclin-dependent kinase inhibitor 2a (Cdkn2a) promoter to specifically partially reprogram aged and stressed cells in a mouse model of Hutchinson-Gilford progeria syndrome (HGPS). Mice showed reduced expression of proinflammatory cytokines and extended life spans upon aged cell-specific OSK expression. The bone marrow and spleen, in particular, showed pronounced gene expression changes, and partial reprogramming in aged HGPS mice led to a shift in the cellular composition of the hematopoietic stem cell compartment toward that of young mice. Administration of AAVs carrying Cdkn2a-OSK to naturally aged wild-type mice also delayed aging phenotypes and extended life spans without altering the incidence of tumor development. Furthermore, intradermal injection of AAVs carrying Cdkn2a-OSK led to improved wound healing in aged wild-type mice. Expression of CDKN2A-OSK in aging or stressed human primary fibroblasts led to reduced expression of inflammation-related genes but did not alter the expression of cell cycle-related genes. This targeted partial reprogramming approach may therefore facilitate the development of strategies to improve health and life span and enhance resilience in the elderly.


Subject(s)
Aging , Cellular Reprogramming , Cellular Senescence , Cyclin-Dependent Kinase Inhibitor p16 , Disease Models, Animal , Kruppel-Like Factor 4 , Animals , Kruppel-Like Factor 4/metabolism , Aging/metabolism , Mice , Humans , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Cyclin-Dependent Kinase Inhibitor p16/genetics , Biomarkers/metabolism , Progeria/metabolism , Progeria/genetics , Progeria/pathology , Dependovirus/metabolism , Promoter Regions, Genetic/genetics
2.
J Biochem ; 163(5): 371-380, 2018 May 01.
Article in English | MEDLINE | ID: mdl-29346578

ABSTRACT

It has been reported that daidzein and equol stimulate DNA replication and proliferation of MCF-7 cells. However, their molecular mechanisms of action are still unclear. We examined the effects of daidzein and equol on DNA replication of MCF-7 cells, focusing on MCM2-7 proteins, which function as the replicative helicase. In the presence of either 1 µM of daidzein or equol, the number of cells in S-phase, which was determined by detecting bromodeoxyuridine incorporated into replicated DNA, almost doubled. The total amounts of MCM7 protein and chromatin-bound MCM7 protein increased in the presence of daidzein. The data suggest that phytoestrogens facilitate cell cycle progression in G1-phase by increasing the level of MCM proteins. In the presence of phytoestrogens, phosphorylation of Rb and levels of MCM2, 3 and 7 mRNA increased, suggesting that stimulation of MCM2-7 transcription is involved in the cell cycle progression. Under the same conditions, double-stranded DNA breakage in logarithmically growing MCF-7 cells, which was detected using anti-γ-H2AX antibodies, did not increase in the presence of equol.


Subject(s)
DNA Replication/drug effects , DNA, Neoplasm/drug effects , Equol/pharmacology , Isoflavones/pharmacology , Cell Cycle Proteins/metabolism , DNA, Neoplasm/metabolism , Humans , MCF-7 Cells , Minichromosome Maintenance Complex Component 2/metabolism , Minichromosome Maintenance Complex Component 3/metabolism , Minichromosome Maintenance Complex Component 4/metabolism , Minichromosome Maintenance Complex Component 6/metabolism , Minichromosome Maintenance Complex Component 7/metabolism , Phosphorylation/drug effects , RNA, Messenger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL